Clarivate Plc (16A.F)
- CNW Group
Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024
Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of the Medical Technologies to Watch in 2024 report. This first installment of a two-part series offers a comprehensive predictive analysis of high-growth medical technology markets poised to generate over $1 billion in value or achieve double-digit growth within the next five years.
- CNW Group
New Clarivate Report Indicates Solid Growth in 2024 Global Trademark Filing Activity
Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released the Trademark Filing and Litigation Trends 2024 Report, analyzing six of the key trademark registers from around the world: the United States (U.S.), the European Union (EU), the United Kingdom (U.K.), Mainland China, Japan, and South Korea. The report reveals that trademark filing activity worldwide saw a return to stability and growth in 2023 after three years of market volatility, indicating s
- CNW Group
Clarivate Launches AI-Enhanced Solution to Accelerate Trademark Watching
Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, launched the first publicly available version of Trademark Watch Analyzer today at the 2024 International Trademark Association Annual Meeting. As the next-generation trademark protection solution enhanced by artificial intelligence (AI) and cloud technology, this solution combines Clarivate global trademark and case law data, in-house IP expertise, and cutting-edge AI technology. It will provide faster and mor
